HIV Vaccines, Immunoprophylaxis and Drugs
HIV 疫苗、免疫预防和药物
基本信息
- 批准号:10699245
- 负责人:
- 金额:$ 2.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAbnormal CellAcademiaAntibodiesAntigensAreaAutoimmunityB-LymphocytesBiology of HIV TransmissionCOVID-19 preventionCellular biologyClinical TrialsCollaborationsColoradoCommunicable DiseasesDapivirineDevelopmentDiseaseEducational workshopEvaluation StudiesFoundationsFutureGovernmentHIVHIV InfectionsHIV vaccineHIV-1ImmuneIndustryInfectionInvestigationKnowledgeLearningMediatingMentorsMethodologyMethodsOutcomeParticipantPatientsPharmaceutical PreparationsPhasePreventionPrevention approachPrevention strategyResearchResearch PersonnelResolutionResourcesRoleScienceScientistThinkingUpdateVaccinationVaccine DesignVaccinesWorkcancer cellclinical practicedesigneffective therapyefficacy studyimmunoprophylaxisimprovedinnovationinterestmeetingsmethod developmentmultidisciplinarynext generationnovel strategiesnovel vaccinespandemic diseaseposterspre-exposure prophylaxispreclinical studypreventprogramsprophylacticprospectiverapid growthresponsesymposiumtreatment strategyvaccination strategyvaccine developmentvaccine efficacyvaccine platformvaccine strategy
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled HIV Vaccines, Immunoprophylaxis and
Drugs, organized by Drs. Hanneke Schuitemaker, Steven Deeks and Dennis Burton. The conference will be
held in Keystone, Colorado from June 6 - 10, 2023.
Despite the availability of effective treatment and prevention strategies, the HIV pandemic continues, with
approximately 1.7 million new infections annually. It is critical for there to be more effective prevention
strategies. This Keystone Symposia conference will assemble experts on the biology of HIV transmission and
emerging prevention methods, including vaccines and pre-exposure prophylaxis (PrEP), in order to discuss the
current state-of-the-art in HIV prevention. Specific topics of discussion will include germline vaccination
strategies and updates on the vaccine and PrEP efficacy studies. Additionally, the program will cover the
challenges and opportunities of developing novel strategies in an era of increasingly effective prevention
methods, particularly long-acting PrEP (cabotegravir) and the dapivirine ring, as well as next generation
vaccine and PrEP approaches. The role that HIV prevention resources and advances have had on the
COVID-19 prevention and HIV cure research agendas will also be discussed, with the hope that these three
largely complementary areas of investigation will remain highly synergistic. Finally, this meeting is being held
jointly with the Keystone Symposia conference, B Cell Biology in the Context of Infectious Diseases,
Autoimmunity and B Cell Cancers. This pairing is ideal to discuss how B cell abnormalities contribute to HIV
infection, especially in terms of the potential for antibody-based vaccine development. Participants from both
conferences will have the opportunity to network through shared sessions, mealtimes, and evening poster
sessions.
摘要
要求为题为“艾滋病毒疫苗、免疫预防和
药物,由Hanneke Schuitemaker博士,Steven Deeks和Dennis Burton组织。会议将
于2023年6月6日至10日在科罗拉多的Keystone举行。
尽管有有效的治疗和预防战略,艾滋病毒的流行仍在继续,
每年约有170万新感染者。必须进行更有效的预防,
战略布局这次Keystone研讨会将聚集艾滋病毒传播生物学专家,
新的预防方法,包括疫苗和暴露前预防(PrEP),以讨论
艾滋病预防的最新技术。具体的讨论主题将包括生殖系疫苗接种
疫苗和PrEP有效性研究的策略和更新。此外,该计划将涵盖
在预防日益有效的时代制定新战略的挑战和机遇
方法,特别是长效PrEP(cabotegravir)和dapivirine环,以及下一代
疫苗和PrEP方法。艾滋病毒预防资源和进展对艾滋病的影响
会议还将讨论COVID-19预防和HIV治疗研究议程,希望这三个领域的研究人员能够参与其中。
在很大程度上相互补充的调查领域将继续保持高度的协同作用。最后,
与Keystone研讨会会议,传染病背景下的B细胞生物学,
自身免疫和B细胞癌。这种配对是讨论B细胞异常如何导致艾滋病毒的理想选择
感染,特别是在基于抗体的疫苗开发的潜力方面。的与会者
会议将有机会通过共享会议,用餐时间和晚上的海报网络
sessions.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERRY L. SHEPPARD其他文献
TERRY L. SHEPPARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERRY L. SHEPPARD', 18)}}的其他基金
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
肺动脉高压:最新技术和治疗机会
- 批准号:
10682118 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
妊娠期感染:致病机制、实验进展和临床策略
- 批准号:
10540260 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
微生物群-免疫相互作用的机制-迈向下一个十年
- 批准号:
10753451 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
长期新冠肺炎和 SARS CoV 2 (PASC) 急性后遗症:发病机制和治疗
- 批准号:
10749522 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
传染病、自身免疫和 B 细胞癌症背景下的 B 细胞生物学
- 批准号:
10683443 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
Inflammation in the Lung: Friend or Foe in Viral Infections?
肺部炎症:病毒感染的朋友还是敌人?
- 批准号:
10681956 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
B 细胞和三级淋巴结构:癌症治疗的新兴靶点
- 批准号:
10754008 - 财政年份:2023
- 资助金额:
$ 2.13万 - 项目类别:
相似海外基金
Mechanical sensing mechanism of abnormal cell clusters by surrounding normal cells
周围正常细胞对异常细胞簇的机械传感机制
- 批准号:
20K20189 - 财政年份:2020
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Rvb1 and Rvb2 are physically and functionally connected during normal and abnormal cell growth
Rvb1 和 Rvb2 在正常和异常细胞生长过程中在物理和功能上相连
- 批准号:
352398 - 财政年份:2016
- 资助金额:
$ 2.13万 - 项目类别:
"Born to be Bad": Is Abnormal Cell Mobility Already Present At Initiation?
“生来就是坏的”:异常的细胞迁移性是否在开始时就已经存在?
- 批准号:
8686657 - 财政年份:2014
- 资助金额:
$ 2.13万 - 项目类别:
Molecular mechanisms of abnormal cell proliferation in acute lymphoblastic leukemia of Down syndrome
唐氏综合征急性淋巴细胞白血病细胞异常增殖的分子机制
- 批准号:
23591527 - 财政年份:2011
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of abnormal cell polarity in brain tumor cells
脑肿瘤细胞异常细胞极性分析
- 批准号:
21591887 - 财政年份:2009
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of abnormal cell proliferation in transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome
唐氏综合症短暂性骨髓增生性疾病和急性巨核细胞白血病细胞异常增殖的分子机制
- 批准号:
20591241 - 财政年份:2008
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of cell adhesion signaling in the abnormal cell polarization of cancer cells
细胞粘附信号在癌细胞异常细胞极化中的作用
- 批准号:
17014055 - 财政年份:2005
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Creation and analysis of animal model monitoring abnormal cell replication
监测异常细胞复制的动物模型的创建和分析
- 批准号:
16380194 - 财政年份:2004
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cl^-homeostasis failure and abnormal cell migration by endocrine disruptor cause damage to nervous system
内分泌干扰物导致的Cl^-稳态失灵和异常细胞迁移导致神经系统损伤
- 批准号:
15590207 - 财政年份:2003
- 资助金额:
$ 2.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ROLES OF PLEIOTROPHIN IN NORMAL AND ABNORMAL CELL GROWTH
多效素在正常和异常细胞生长中的作用
- 批准号:
2683586 - 财政年份:1995
- 资助金额:
$ 2.13万 - 项目类别: